Article ID Journal Published Year Pages File Type
10916344 Nuclear Medicine and Biology 2005 9 Pages PDF
Abstract
High tumor-targeting properties of 90Y-DOTA-Re(Arg11)CCMSH and 177Lu-DOTA-Re(Arg11)CCMSH highlighted their potential as radiopharmaceuticals for targeted radionuclide therapy of melanoma in further investigations.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model
Authors
, , ,